Home Cart Sign in  
Chemical Structure| 205187-53-7 Chemical Structure| 205187-53-7

Structure of CX-157
CAS No.: 205187-53-7

Chemical Structure| 205187-53-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CX-157 is a reversible inhibitor of monoamine oxidase-A (MAO-A) with an EC50 of 19.3 ng/mL.

Synonyms: CX-157

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CX-157

CAS No. :205187-53-7
Formula : C14H8F4O4S
M.W : 348.27
SMILES Code : FC(F)(F)COC1=CC(OC2=CC(F)=CC=C2S3(=O)=O)=C3C=C1
Synonyms :
CX-157
MDL No. :MFCD18633273

Safety of CX-157

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00739908 Major Depressive Disorder Phase 2 Completed - United States, Alabama ... More >> Birmingham Research Group Birmingham, Alabama, United States, 35216 United States, California Southwestern Research, Inc. Beverly Hills, California, United States United States, District of Columbia The George Washington University Washington, District of Columbia, United States United States, Florida Irving S. Kolin, M.D. Winter Park, Florida, United States, 32789 United States, Illinois Midwest Center for Neurobehavioral Medicine Oakbrook Terrace, Illinois, United States United States, Maryland Capital Clinical Research Associates Rockville, Maryland, United States United States, Massachusetts McLean Hospital Belmont, Massachusetts, United States United States, New Jersey CRI Worldwide, LLC Clementon, New Jersey, United States United States, New York Fieve Clinical Services New York, New York, United States United States, North Carolina Richard H. Weisler, M.D., P.A. Raleigh, North Carolina, United States United States, Pennsylvania University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States United States, Texas FutureSearch Trials Austin, Texas, United States, 78756 United States, Washington Summit Research Network (Seattle), LLC Seattle, Washington, United States United States, Wisconsin Northbrooke Research Center Brown Deer, Wisconsin, United States Less <<
NCT01246908 Treatment Resistant Depression Phase 2 Completed - -
NCT01633437 Major Depressive Disorder Phase 1 Completed - United States, Florida ... More >> Comprehensive Phase One Miramar, Florida, United States, 33025 Less <<
NCT00739908 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.87mL

0.57mL

0.29mL

14.36mL

2.87mL

1.44mL

28.71mL

5.74mL

2.87mL

 

Historical Records

Categories